Amyloid-PET imaging predicts functional decline in clinically normal individuals.
Quenon L, Collij LE, Garcia DV, Lopes Alves I, Gérard T, Malotaux V, Huyghe L, Gispert JD, Jessen F, Visser PJ, den Braber A, Ritchie CW, Boada M, Marquié M, Vandenberghe R, Luckett ES, Schöll M, Frisoni GB, Buckley C, Stephens A, Altomare D, Ford L, Birck C, Mett A, Gismondi R, Wolz R, Grootoonk S, Manber R, Shekari M, Lhommel R, Dricot L, Ivanoiu A, Farrar G, Barkhof F, Hanseeuw BJ; AMYPAD Consortium.
Quenon L, et al. Among authors: barkhof f.
Alzheimers Res Ther. 2024 Jun 17;16(1):130. doi: 10.1186/s13195-024-01494-9.
Alzheimers Res Ther. 2024.
PMID: 38886831
Free PMC article.